RecruitingNot ApplicableNCT06987552

Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients

A Pilot Study of Single-Port Robot-Assisted Surgery Using Da Vinci SP Surgical System for Patients With Upper Tract Urothelial Cancer


Sponsor

National Taiwan University Hospital

Enrollment

25 participants

Start Date

Dec 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate patient-reported outcomes of radical nephroureterectomy using single-port robotic surgery


Eligibility

Min Age: 20 Years

Inclusion Criteria6

  • Age 20 years or more
  • Histologically or cytologically diagnosed upper tract urothelial cancer
  • Fitting indications of radical nephroureterectomy and ipsilateral bladder cuff resection, and deemed feasible for robotic surgery
  • ASA physical status classification 1-2 and adequate organ function
  • Patients willing and able to comply with study protocol requirements and follow-up
  • With informed consent

Exclusion Criteria13

  • Synchronous bladder cancer
  • Distant metastasis of cancer
  • BMI ≥30 or BMI <18.5
  • Unable to tolerate lateral decubitus or Trendelenburg position (relative contra-indication)
  • Severe adhesion due to prior abdominopelvic surgery (relative contra-indication)
  • Previous radiation treatment to the pelvic area
  • Active infectious disease
  • Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic interventions, such as: severe heart disease (NYHA functional class III-IV) or severe lung disease (GOLD Group C-D)
  • Cannot follow trial-required procedures
  • Concomitant systemic or pelvic disease that increases the risk of surgery
  • Long-term use of anti-coagulant(s)
  • Patients with coagulopathy
  • Emergency surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDa Vinci SP Surgical System

Da Vinci SP Surgical System


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06987552


Related Trials